PPARGC1A and hypertensive disorder: Craige et al., created mice with endothelial-specific loss of function (PGC-1α EC KO) that showed significantly reduced PGC-1α expression as well as decreased endothelial NO synthase (eNOS) expression and NO• bioactivity in response to angiotensin-II-induced hypertension [121].